These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27018266)

  • 21. Brachyury as a potential modulator of androgen receptor activity and a key player in therapy resistance in prostate cancer.
    Pinto F; Pértega-Gomes N; Vizcaíno JR; Andrade RP; Cárcano FM; Reis RM
    Oncotarget; 2016 May; 7(20):28891-902. PubMed ID: 27049720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of Brachyury gene is a significant prognostic factor for primary lung carcinoma.
    Haro A; Yano T; Kohno M; Yoshida T; Koga T; Okamoto T; Takenoyama M; Maehara Y
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S509-16. PubMed ID: 23456319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transactivation of SOX5 by Brachyury promotes breast cancer bone metastasis.
    Chen M; Zou S; He C; Zhou J; Li S; Shen M; Cheng R; Wang D; Zou T; Yan X; Huang Y; Shen J
    Carcinogenesis; 2020 Jul; 41(5):551-560. PubMed ID: 31713604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of brachyury by fibroblast growth factor receptor 1 in lung cancer.
    Hu Y; Feng X; Mintz A; Petty WJ; Hsu W
    Oncotarget; 2016 Dec; 7(52):87124-87135. PubMed ID: 27893433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of Cancer Vaccines Targeting Brachyury, a Transcription Factor Associated with Tumor Epithelial-Mesenchymal Transition.
    Hamilton DH; David JM; Dominguez C; Palena C
    Cells Tissues Organs; 2017; 203(2):128-138. PubMed ID: 28214895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune Targeting of Tumor Epithelial-Mesenchymal Transition via Brachyury-Based Vaccines.
    Palena C; Hamilton DH
    Adv Cancer Res; 2015; 128():69-93. PubMed ID: 26216630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I Study of a Poxviral TRICOM-Based Vaccine Directed Against the Transcription Factor Brachyury.
    Heery CR; Palena C; McMahon S; Donahue RN; Lepone LM; Grenga I; Dirmeier U; Cordes L; Marté J; Dahut W; Singh H; Madan RA; Fernando RI; Hamilton DH; Schlom J; Gulley JL
    Clin Cancer Res; 2017 Nov; 23(22):6833-6845. PubMed ID: 28855356
    [No Abstract]   [Full Text] [Related]  

  • 28. Knockdown of the T-box transcription factor Brachyury increases sensitivity of adenoid cystic carcinoma cells to chemotherapy and radiation in vitro: implications for a new therapeutic principle.
    Kobayashi Y; Sugiura T; Imajyo I; Shimoda M; Ishii K; Akimoto N; Yoshihama N; Mori Y
    Int J Oncol; 2014 Apr; 44(4):1107-17. PubMed ID: 24504414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The human T-box mesodermal transcription factor Brachyury is a candidate target for T-cell-mediated cancer immunotherapy.
    Palena C; Polev DE; Tsang KY; Fernando RI; Litzinger M; Krukovskaya LL; Baranova AV; Kozlov AP; Schlom J
    Clin Cancer Res; 2007 Apr; 13(8):2471-8. PubMed ID: 17438107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Brachyury on epithelial-mesenchymal transitions and chemosensitivity in non-small cell lung cancer.
    Xu K; Liu B; Liu Y
    Mol Med Rep; 2015 Jul; 12(1):995-1001. PubMed ID: 25683840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Putative oncogene Brachyury (T) is essential to specify cell fate but dispensable for notochord progenitor proliferation and EMT.
    Zhu J; Kwan KM; Mackem S
    Proc Natl Acad Sci U S A; 2016 Apr; 113(14):3820-5. PubMed ID: 27006501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and characterization of a cytotoxic T-lymphocyte agonist epitope of brachyury, a transcription factor involved in epithelial to mesenchymal transition and metastasis.
    Tucker JA; Jochems C; Boyerinas B; Fallon J; Greiner JW; Palena C; Rodell TC; Schlom J; Tsang KY
    Cancer Immunol Immunother; 2014 Dec; 63(12):1307-17. PubMed ID: 25186612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brachyury regulates proliferation of cancer cells via a p27Kip1-dependent pathway.
    Jezkova J; Williams JS; Jones-Hutchins F; Sammut SJ; Gollins S; Cree I; Coupland S; McFarlane RJ; Wakeman JA
    Oncotarget; 2014 Jun; 5(11):3813-22. PubMed ID: 25003467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberrant expression of the embryonic transcription factor brachyury in human tumors detected with a novel rabbit monoclonal antibody.
    Hamilton DH; Fernando RI; Schlom J; Palena C
    Oncotarget; 2015 Mar; 6(7):4853-62. PubMed ID: 25605015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. WEE1 inhibition alleviates resistance to immune attack of tumor cells undergoing epithelial-mesenchymal transition.
    Hamilton DH; Huang B; Fernando RI; Tsang KY; Palena C
    Cancer Res; 2014 May; 74(9):2510-9. PubMed ID: 24626094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brachyury, a vaccine target, is overexpressed in triple-negative breast cancer.
    Hamilton DH; Roselli M; Ferroni P; Costarelli L; Cavaliere F; Taffuri M; Palena C; Guadagni F
    Endocr Relat Cancer; 2016 Oct; 23(10):783-796. PubMed ID: 27580659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer.
    Islam SS; Mokhtari RB; Noman AS; Uddin M; Rahman MZ; Azadi MA; Zlotta A; van der Kwast T; Yeger H; Farhat WA
    Mol Carcinog; 2016 May; 55(5):537-51. PubMed ID: 25728352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The embryonic Brachyury transcription factor is a novel biomarker of GIST aggressiveness and poor survival.
    Pinto F; Campanella NC; Abrahão-Machado LF; Scapulatempo-Neto C; de Oliveira AT; Brito MJ; Andrade RP; Guimarães DP; Reis RM
    Gastric Cancer; 2016 Apr; 19(2):651-659. PubMed ID: 25995035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
    Geng S; Guo Y; Wang Q; Li L; Wang J
    Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury.
    Heery CR; Singh BH; Rauckhorst M; Marté JL; Donahue RN; Grenga I; Rodell TC; Dahut W; Arlen PM; Madan RA; Schlom J; Gulley JL
    Cancer Immunol Res; 2015 Nov; 3(11):1248-56. PubMed ID: 26130065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.